Brian P. Riesenberg, Ephraim A. Ansa-Addo, Jennifer Gutierrez, Cynthia D. Timmers, Bei Liu and Zihai Li J Immunol September 1, 2019, 203 (5) 1105-1110; DOI: https://doi.org/10.4049/jimmunol.1900594 Key Points Platelets alter frequency, phenotype, and function of tumor-infiltrating lymphocytes. Inhibition of platelet activation improves CD8+ T cell–dependent tumor control. Pretreatment with antiplatelet therapy enhances responsiveness to PD-1 blockade.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile